🔎 Trials Near Me

Home › Cushing's Syndrome

Cushing's Syndrome clinical trials recruiting in the U.S.

12 studies for Cushing's Syndrome are recruiting participants at sites across the United States.

Cushing's Syndrome (Hypercortisolism) is a rare hormonal disorder caused by over exposure to the hormone, Cortisol. Lab tests can show if you have it.

Cities with the most studies

By state

Recently updated studies

Evaluation of Adults With Endocrine and Metabolic-Related Conditions

RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 100 · All sexes · Updated Sep 28, 2026 · NCT02830308

Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome

RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 28, 2026 · NCT02019706

Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07138274

Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism

RecruitingPhase 2
Ages 18 to 120 · All sexes · Updated Sep 23, 2026 · NCT06246357

Recovery From Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS)

RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT04543253

A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement

RecruitingObservational study
Ages 18 to 75 · All sexes · Updated Sep 9, 2026 · NCT06430528

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07296484

Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome

RecruitingPhase 2Healthy volunteers welcome
Ages 18 to 70 · All sexes · Updated Aug 31, 2026 · NCT06635629

IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion

Recruiting
Ages 18 and older · All sexes · Updated Mar 27, 2026 · NCT07361874

Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome

RecruitingPhase 2
Ages 2 to 17 · All sexes · Updated Mar 27, 2026 · NCT03708900

Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 11, 2026 · NCT07104812

Collecting Information About Treatment Results for Patients With Cushing's Syndrome

RecruitingObservational study
Ages 14 and older · All sexes · Updated Oct 23, 2025 · NCT03364803

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.